These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 15183893

  • 21. Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases.
    Giles FJ, Cooper MA, Silverman L, Karp JE, Lancet JE, Zangari M, Shami PJ, Khan KD, Hannah AL, Cherrington JM, Thomas DA, Garcia-Manero G, Albitar M, Kantarjian HM, Stopeck AT.
    Cancer; 2003 Apr 15; 97(8):1920-8. PubMed ID: 12673719
    [Abstract] [Full Text] [Related]

  • 22. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2.
    Alonso V, de Gortázar AR, Ardura JA, Andrade-Zapata I, Alvarez-Arroyo MV, Esbrit P.
    J Cell Physiol; 2008 Dec 15; 217(3):717-27. PubMed ID: 18651620
    [Abstract] [Full Text] [Related]

  • 23. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y, Zhong Z, Huber J, Bassi R, Finnerty B, Corcoran E, Li H, Navarro E, Balderes P, Jimenez X, Koo H, Mangalampalli VR, Ludwig DL, Tonra JR, Hicklin DJ.
    Clin Cancer Res; 2006 Nov 01; 12(21):6573-84. PubMed ID: 17085673
    [Abstract] [Full Text] [Related]

  • 24. Functional VEGF and VEGF receptors are expressed in human medulloblastomas.
    Slongo ML, Molena B, Brunati AM, Frasson M, Gardiman M, Carli M, Perilongo G, Rosolen A, Onisto M.
    Neuro Oncol; 2007 Oct 01; 9(4):384-92. PubMed ID: 17704359
    [Abstract] [Full Text] [Related]

  • 25. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S, Dokun AO, Li Y, Popel AS, Kontos CD, Annex BH.
    Circ Res; 2007 Oct 26; 101(9):948-56. PubMed ID: 17823371
    [Abstract] [Full Text] [Related]

  • 26. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects.
    Detoraki A, Staiano RI, Granata F, Giannattasio G, Prevete N, de Paulis A, Ribatti D, Genovese A, Triggiani M, Marone G.
    J Allergy Clin Immunol; 2009 May 26; 123(5):1142-9, 1149.e1-5. PubMed ID: 19275959
    [Abstract] [Full Text] [Related]

  • 27. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S, Mehta S, Haque I, Sengupta K, Dhar K, Kambhampati S, Van Veldhuizen PJ, Banerjee SK.
    Biochemistry; 2008 Mar 18; 47(11):3345-51. PubMed ID: 18284215
    [Abstract] [Full Text] [Related]

  • 28. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y, Wang S, Hoot DR, Clinton SK.
    J Nutr Biochem; 2007 Jun 18; 18(6):408-17. PubMed ID: 17142033
    [Abstract] [Full Text] [Related]

  • 29. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V, Mukunyadzi P, Dennis RA, Siegel ER, Johnson DE, Kohli M.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [Abstract] [Full Text] [Related]

  • 30. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG, Kim TD, Li G, Yoon WH, Chae CB.
    Clin Cancer Res; 2005 Apr 01; 11(7):2651-61. PubMed ID: 15814646
    [Abstract] [Full Text] [Related]

  • 31. VEGF receptor signaling and endothelial function.
    Kliche S, Waltenberger J.
    IUBMB Life; 2001 Jul 01; 52(1-2):61-6. PubMed ID: 11795595
    [Abstract] [Full Text] [Related]

  • 32. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
    Hayashi H, Nakagami H, Takami Y, Koriyama H, Mori M, Tamai K, Sun J, Nagao K, Morishita R, Kaneda Y.
    Arterioscler Thromb Vasc Biol; 2009 Jun 01; 29(6):909-14. PubMed ID: 19325137
    [Abstract] [Full Text] [Related]

  • 33. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B, Ni J, Vatish M, Singer DR.
    Microcirculation; 2008 Apr 01; 15(3):251-67. PubMed ID: 18386220
    [Abstract] [Full Text] [Related]

  • 34. Role of angiogenesis inhibitors in acute myeloid leukemia.
    Fiedler W, Staib P, Kuse R, Dührsen U, Flasshove M, Cavalli F, Hossfeld DK, Berdel WE.
    Cancer J; 2001 Apr 01; 7 Suppl 3():S129-33. PubMed ID: 11779083
    [Abstract] [Full Text] [Related]

  • 35. Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining.
    Kharfan-Dabaja MA, Patel SA, Osunkoya AO, Kojouri K, Kamble R, Yang J, Hashmi M, Ozer H, Selby GB.
    Clin Lab Haematol; 2006 Aug 01; 28(4):254-8. PubMed ID: 16898965
    [Abstract] [Full Text] [Related]

  • 36. [Expression of vascular endothelial growth factor and its receptors KDR and Flt1 in acute myeloid leukemia].
    Wang Y, Xiao ZJ, Liu P, Yang C, Yang RC, Cai YL, Han ZC.
    Zhonghua Xue Ye Xue Za Zhi; 2003 May 01; 24(5):249-52. PubMed ID: 12859876
    [Abstract] [Full Text] [Related]

  • 37. Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia.
    O'Farrell AM, Yuen HA, Smolich B, Hannah AL, Louie SG, Hong W, Stopeck AT, Silverman LR, Lancet JE, Karp JE, Albitar M, Cherrington JM, Giles FJ.
    Leuk Res; 2004 Jul 01; 28(7):679-89. PubMed ID: 15158089
    [Abstract] [Full Text] [Related]

  • 38. An engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells.
    Heil M, Mitnacht-Krauss R, Issbrücker K, van den Heuvel J, Dehio C, Schaper W, Clauss M, Weich HA.
    Angiogenesis; 2003 Jul 01; 6(3):201-11. PubMed ID: 15041796
    [Abstract] [Full Text] [Related]

  • 39. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A, Robak T, Wrzesień-Kuś A, Krawczyńska A, Lech-Marańda E, Urbańska-Ryś H.
    Eur Cytokine Netw; 2003 Jul 01; 14(3):149-53. PubMed ID: 14656688
    [Abstract] [Full Text] [Related]

  • 40. Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2.
    Patel NS, Mathura VS, Bachmeier C, Beaulieu-Abdelahad D, Laporte V, Weeks O, Mullan M, Paris D.
    J Neurochem; 2010 Jan 01; 112(1):66-76. PubMed ID: 19818105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.